SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-027613
Filing Date
2022-08-03
Accepted
2022-08-03 07:16:49
Documents
113
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-10q_20220630.htm   iXBRL 10-Q 5277331
2 EX-10.3 ex10_3.htm EX-10.3 86954
3 EX-10.4 ex10_4.htm EX-10.4 44918
4 EX-10.5 ex10_5.htm EX-10.5 86501
5 EX-10.6 ex10_6.htm EX-10.6 14198
6 EX-31.1 hznp-ex311_1110.htm EX-31.1 16081
7 EX-31.2 hznp-ex312_1088.htm EX-31.2 15819
8 EX-32.1 hznp-ex321_1086.htm EX-32.1 8966
9 EX-32.2 hznp-ex322_1087.htm EX-32.2 8972
  Complete submission text file 0001564590-22-027613.txt   18613720

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA hznp-20220630.xsd EX-101.SCH 103747
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20220630_cal.xml EX-101.CAL 96272
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20220630_def.xml EX-101.DEF 407000
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20220630_lab.xml EX-101.LAB 727762
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20220630_pre.xml EX-101.PRE 636359
107 EXTRACTED XBRL INSTANCE DOCUMENT hznp-10q_20220630_htm.xml XML 3857986
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 221130911
SIC: 2834 Pharmaceutical Preparations